LBO — TEXAS HEALTH SOUTHWEST
IRR: 17.1% | MOIC: 2.20x
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
17.1%
IRR
2.20x
MOIC
$389.5M
Entry EV
$598.9M
Exit EV
$200.4M
Equity Invested
Sources & Uses
S&UTotal · $389.5M| Item | Amount | % | Distribution |
|---|---|---|---|
| Senior Debt | $151.3M | 38.8% | |
| Sub Debt | $37.8M | 9.7% | |
| Equity | $200.4M | 51.5% | |
| Enterprise Value | $378.1M | 97.1% | |
| Transaction Fees | $11.3M | 2.9% | |
| Total Uses | $389.5M | 100.0% |
Interpretation
INTAt 2.20x MOIC and 17.1% IRR over 5 years, this deal meets the 15-20% range — acceptable with operational upside.
Key drivers: Check the EBITDA bridge to identify highest-probability levers, the debt schedule for leverage trajectory, or the challenge solver to see what breaks the deal.
Returns Waterfall
WFL| Component | Value |
|---|---|
| Exit Ebitda | $57.0M |
| Exit Ev | $598.9M |
| Net Debt At Exit | $157.0M |
| Equity At Exit | $441.8M |
| Equity Invested | $200.4M |
| Total Value Created | $241.4M |
| Value From Growth | $201.8M |
| Value From Multiple | $18.9M |
| Value From Deleveraging | $32.0M |